CSIMarket
 
Nuoncology Labs Inc   (TIHE)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 
Price: $0.0001 $-3.30 -99.997%
Day's High: $0.0001 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) -
 Employees -
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) 0
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Nuoncology Labs Inc
Nuoncology Labs Inc is a biotechnology company that focuses on developing innovative cancer treatments. The company utilizes advanced scientific research and technologies to develop novel drug candidates that target specific types of cancer cells. Nuoncology Labs Inc aims to improve patient outcomes by creating personalized treatment options that are effective and less toxic than traditional therapies. Through its research and development efforts, the company is working towards finding breakthrough solutions for various types of cancer, ultimately contributing to the advancement of cancer care.


   Company Address: 7339 E. Williams Drive Scottsdale 85255 AZ
   Company Phone Number: 793.8058   Stock Exchange / Ticker: TIHE


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Taihe Group Inc

Taihe Group Inc Reports Operating Deficit of $-0.019187 Million in Q1 2023, Reflecting Potential Challenges for Medical Laboratories Industry

The Medical Laboratories industry has been a key player in the healthcare sector, providing essential diagnostic services and playing a crucial role in patient care. As the reporting season for the first quarter of 2023 progresses, we have seen a wave of financial disclosures from companies in this industry. Among them is Taihe Group Inc (TIHE), a prominent player in the Medical Laboratories sector.
In its recent financial report, TIHE revealed an operating deficit of $-0.019187 million for the first quarter of 2023. This figure serves as a yardstick to measure the current performance level of the company. To gain a better understanding of the company's trajectory, we can compare this deficit to that of the first quarter of 2022, which stood at $-0.012281 million. It is evident that the deficit has increased, implying some challenges in the past fiscal period.










Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com